Abstract
The effects of chronic marijuana (MJ) use on brain function remain controversial. Because MJ is often used by human immunodeficiency virus (HIV) patients, the aim of this study was to evaluate whether chronic MJ use and HIV infection are associated with interactive or additive effects on brain chemistry and cognitive function. We evaluated 96 subjects (30 seronegative nondrug users, 24 MJ users, 21 HIV without MJ use, 21 HIV + MJ) using proton magnetic resonance spectroscopy and a battery of neuropsychological tests. The two primarily abstinent MJ user groups showed no significant differences on calculated estimates of lifetime grams of delta9-tetrahydrocannabinol exposure, despite some differences in usage pattern. The two HIV groups also had similar HIV disease severity (CD4 cell count, plasma viral load, HIV dementia staging, Karnofsky score). On two-way analyses of covariance, HIV infection (independent of MJ) was associated with trends for reduced N-acetyl aspartate (NA) in the parietal white matter and increased choline compounds (CHO) in the basal ganglia. In contrast, MJ (independent of HIV) was associated with decreased basal ganglia NA (−5.5%, p = 0.05), CHO (−10.6%, p = 0.04), and glutamate (−9.5%, p = 0.05), with increased thalamic creatine (+6.1%, p = 0.05). HIV + MJ was associated with normalization of the reduced glutamate in frontal white matter (interaction p = 0.01). After correction for age, education, or mood differences, MJ users had no significant abnormalities on neuropsychological test performance, and HIV subjects only had slower reaction times. These findings suggest chronic MJ use may lead to decreased neuronal and glial metabolites, but may normalize the decreased glutamate in HIV patients.
Similar content being viewed by others
References
Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu M, Gray F (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25:123–133
Anonymous (1994) Army individual test battery: manual of directions and scoring. War Department, Adjutant General's Office, Washington, DC
Blair J, Spreen O (1989) The new adult reading test—revised manual. University of Victoria, Victoria, Canada
Bolla K, Brown K, Eldreth D, Tate K, Cadet J (2002) Dose-related neurocognitive effects of marijuana use. Neurology 9:1337–1343
Bolla K, Eldreth D, Matochik J, Cadet J (2005) Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage 26:480–492
Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 15:289–298
Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, Vago L (1987) Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical and electron microscopical study of 100 autopsy cases. Acta Neuropathol 75:185–198
Cabral GA, Dove Pettit DA (1998) Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol 83:116–123
Chang L, Ernst T, Poland R, Jenden D (1996) In vivo proton magnetic resonance spectroscopy of the normal human aging brain. Life Sci 58:2049–2056
Chang L, Ernst T, Strickland T, Mehringer CM (1999a) Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. Am J Psychiatry 156:716–722
Chang L, Ernst T, Grob CS, Poland RE (1999b) Cerebral 1H MRS abnormalities in 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) users. J Magn Reson Imaging 10:521–526
Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E (1999c) Cerebral metabolite abnormalities correlate with clinical severity of HIV-cognitive motor complex. Neurology 52:100–108
Chang L, Ernst T, Leonido-Yee M, Speck O (2000) Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 54:389–396
Chang L, Ernst T, Witt M, Ames N, Jocivich J, Speck O, Gaiefsky M, Walot I, Miller E (2002) Relationships among cerebral metabolites, cognitive function and viral loads in antiretroviral-naïve HIV patients. NeuroImage 17:1638–1648
Chang L, Tomasi D, Yakupov R, Lozar C, Arnold S, Caparelli E, Ernst T. Adaptation of the attention network in human immunodeficiency virus brain injury. Ann. Neurol. 56:259–272, 2004.
Charalambous A, Marciniak G, Shiue C, Dewey S, Schlyer D, Wolf A, Makriyannis A (1991) PET studies in the primate brain and biodistribution in mice using (−)-5′-18F-delta 8-THC. Pharmacol Biochem Behav 40:503–507
Copper J, Bloom F, Roth R (1996) The Biochemical Basis of Neuropharmacology seventh edition, Oxford University Press, Inc. New York
Cristiani SA, Pukay-Martin ND, Bornstein RA (2004) Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci 16:330–335
Eldreth D, Matochik J, Cadet J, Bolla K (2004) Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. NeuroImage 23:914–920
Ernst T, Kreis R, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson B102:1–8
Ernst T, Chang L, Leonido-Yee M, Speck O (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54:1344–1349
Ernst T, Chang L, Arnold S (2003) Increased glial markers predict increased working memory network activation in HIV patients. NeuroImage 19:1686–1693
Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57:671–675
Goncharov I, Weiner L, Vogel Z (2005) Delta9-tetrahydrocannabinol increases C6 glioma cell death produced by oxidative stress. Neuroscience 134:567–574
Grant I, Atkinson J, Hesselink J (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other immunodeficiency virus (HIV) infections. Ann Intern Med 107:828–836
Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T (2003) Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc 9:679–689
Gruber SA, Yurgelun-Todd DA (2005) Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res 23:107–118
Heaton R, Grant I, Butters N, White D, Kirson D, Atkinson J, McCutchan J, Taylor M, Kelly M, Ellis R (1995) The HNRC 500—neuropsychology of HIV infection at different stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1:231–251
Ke Y, Streeter C, Nassar L, Sarid-Segal O, Hennen J, Yurgelun-Todd D, Awad L, Rendall M, Gruber S, Nason A, Mudrick M, Blank S, Meyer A, Knapp C, Ciraulo D, Renshaw P (2004) Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 130:283–293
Klein TW, Friedman H, Specter S (1998) Marijuana, immunity and infection. J Neuroimmunol 83:102–115
Klein TW, Lane B, Newton CA, Friedman H (2000) The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 225:1–8
Kløve H (1963) Clinical neuropsychology. In: Forster F (ed) The Medical Clinics of North America, WB Saunders, New York, pp 110–125
Kreis R, Ernst T, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B102:9–19
Lee JH, Garwood M, Menon R, Adriany G, Andersen P, Truwit CL, Ugurbil K (1995) High contrast and fast three-dimensional magnetic resonance imaging at high fields. Magn Reson Med 34:308–312
Maccarrone M, Finazzi-Agro A (2003) The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 10:946–955
Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80:448–456
Martin E, Pitrak D, Pursell K, Mullane K, Novak R (1995) Delayed recognition memory span in HIV-1 infection. J Int Neuropsychol Soc 1:575–580
Miller EN (1990) California Computerized Assessment Package. In Custom Edition, Norland Software, Los Angeles
Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B (1990) Neuropsychological performance in HIV-1 infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 40:197–203
O'Leary D, Block R, Koeppel J, Flaum M, Schultz S, Andreasen N, Ponto L, Watkins G, Hurtig R, Hichwa R (2002) Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 26:802–816
Patel N, Moldow R, Patel J, Wu G, Chang S (1998) Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. Brain Res 797:225–233
Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, Devoto P (2002) Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res 948:155–158
Pope HJ, Yurgelun-Todd D (1996) The residual cognitive effects of heavy marijuana use in college students. J Am Med Assoc 275:521–527
Pope HJ, Gruber A, Hudson J, Huestis M, Yurgelun-Todd D (2001) Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58:909–915
Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586–592
Provencher S (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672
Radloff LL (1997) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
Rey A (1941) L'examen psycholoqiue dans les cas d'encephalopathie traumatique. Arch Psychol 28:286–340
Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW (1996)Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 37:1133–1141
Shen M, Thayer SA (1999) Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol 55:8–13
Smith A (1982) Symbol Digit Modalities Test: Western Psychological Services
Soher B, Hurd R, Sailasuta N, Barker P (1996) Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 36:335–339
Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. J Am Med Assoc 287:1123–1131
Stroop J (1935) Studies of interference in serial verbal reaction. J Exp Psychol 18:643–662
Tomasini MC, Ferraro L, Bebe BW, Tanganelli S, Cassano T, Cuomo V, Antonelli T (2002) Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors. J Neurosci Res 68:449–453
Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio M, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retrovir 21:706–713
Volkow N, Gillespie H, Mullani N, Tancredi L, Grant C, Valentine A, Hollister L (1996) Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res 67:29–38
Watson SJ, Benson JA Jr, Joy JE (2000) Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch Gen Psychiatry 57:547–552
Acknowledgements
This work was supported in part by funds from NIH [K24-DA16170, K02-DA16991, and T32 DA07316] and the Department of Energy (Office of Environmental Research). We are grateful to the research subjects who participated in this study. We also thank K. Warren and L. Zimmerman for subject recruitment, K. Leckova for subject evaluation, and S. Arnold, D. Tomasi, C. Lozar, and E. Caparelli for some of the MRS data acquisition.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chang, L., Cloak, C., Yakupov, R. et al. Combined and Independent Effects of Chronic Marijuana Use and HIV on Brain Metabolites. Jrnl NeuroImmune Pharm 1, 65–76 (2006). https://doi.org/10.1007/s11481-005-9005-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-005-9005-z